Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s13045-021-01046-w http://scihub22266oqcxt.onion/10.1186/s13045-021-01046-w 33640005!7910769!33640005     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Hematol+Oncol 2021 ; 14 (1): 38 Nephropedia Template TP {{tp|p=33640005|t=2021. COVID-19 vaccines for patients with cancer: benefits likely outweigh risks |pdf=|usr=}}{{33640005}} gab.com Text COVID-19 vaccines for patients with cancer: benefits likely outweigh risks JO: J Hematol Oncol http://www.kidney.de/pget.php?&tw=1&pmid=33640005 #FOAvip Less than a year since the start of the COVID-19 pandemic, ten vaccines against SARS-CoV-2 have been approved for at least limited use, with over sixty others in clinical trials. This swift achievement has generated excitement and arrives at a time of great need, as the number of COVID-19 cases worldwide continues to rapidly increase. Two vaccines are currently approved for full use, both built on mRNA and lipid nanotechnology platforms, a success story of mRNA technology 20 years in the making. For patients with cancer, questions arise around the safety and efficacy of these vaccines in the setting of immune alterations engendered by their malignancy and/or therapies. We summarize the current data on leading COVID-19 vaccine candidates and vaccination of patients undergoing immunomodulatory cancer treatments. Most current cancer therapeutics should not prevent the generation of protective immunity. We call for more research in this area and recommend that the majority of patients with cancer receive COVID vaccinations when possible. Twit Text FOAVip COVID-19 vaccines for patients with cancer: benefits likely outweigh risks ????J Hematol Oncol http://www.kidney.de/pget.php?&tw=1&pmid=33640005 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33640005 #FOAvip English Wikipedia <ref>{{Cite pmid|33640005}}</ref> COVID-19 vaccines for patients with cancer: benefits likely outweigh risks #MMPMID33640005 Hwang JK; Zhang T; Wang AZ; Li Z J Hematol Oncol 2021[Feb]; 14 (1): 38 PMID33640005show ga Less than a year since the start of the COVID-19 pandemic, ten vaccines against SARS-CoV-2 have been approved for at least limited use, with over sixty others in clinical trials. This swift achievement has generated excitement and arrives at a time of great need, as the number of COVID-19 cases worldwide continues to rapidly increase. Two vaccines are currently approved for full use, both built on mRNA and lipid nanotechnology platforms, a success story of mRNA technology 20 years in the making. For patients with cancer, questions arise around the safety and efficacy of these vaccines in the setting of immune alterations engendered by their malignancy and/or therapies. We summarize the current data on leading COVID-19 vaccine candidates and vaccination of patients undergoing immunomodulatory cancer treatments. Most current cancer therapeutics should not prevent the generation of protective immunity. We call for more research in this area and recommend that the majority of patients with cancer receive COVID vaccinations when possible. |Animals[MESH] |Antineoplastic Agents/therapeutic use[MESH] |COVID-19 Vaccines/adverse effects/immunology/*therapeutic use[MESH] |COVID-19/*complications/immunology/*prevention & control[MESH] |Humans[MESH] |Immunotherapy[MESH] |Neoplasms/*complications/immunology/therapy[MESH]COVID-19 vaccines for patients with cancer: benefits likely outweigh r(epmc).pdf DeepDyve Pubget Overpricing